VWF propeptide: A useful marker in VWD

Blood

Volumn 108, Issue 10, 2006, Pages 3229-3230

  Federici, Augusto B ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DESMOPRESSIN; VON WILLEBRAND FACTOR;

BLOOD VESSEL WALL; GENETIC DISORDER; HEMOSTASIS; HUMAN; MEDICAL SOCIETY; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURVIVAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

EID: 33751189833     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-09-043117     Document Type: Note

References (5)

1. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol. 1990;6:217-246.
2. Borchiellini A, Fijnvandraat K, ten Cate JW, et al. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-vasopressin in humans. Blood. 1996;88:2951-2958.
3. Federici AB, Mazurier C, Berntorp E, et al. Biological response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood. 2004;103:2032-2038.
4. Lenting PJ, Westein E, Terraube V, et al. An experimental model to study the in vivo survival of von Willebrand factor: basic aspects and application to the R1205H mutation. J. Biol Chem. 2004;279:12102-12109.
5. Van Genderen PJ, Boerttjes RC, van Mourik JA. Quantitative analysis of von Willebrand factor and its pro-peptide in plasma of acquired von Willebrand syndrome. Thromb Haemost. 1998;80:495-498.